FDA aims to publish Essure safety review in February

The Food and Drug Administration posted a brief statement online about its review of the metallic device, Essure, which has been subject to thousands of complaints by women reporting chronic pain, bleeding and headaches. The Essure implant has been sold for more than a decade and is frequently pitched to women as the only non-surgical option for permanent birth control.